Farallon Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
43,225
-3
| -0% | -$70 | ﹤0.01% | 84 |
|
|
2025
Q1 | $658K | Hold |
43,228
| – | – | ﹤0.01% | 88 |
|
|
2024
Q4 | $794K | Sell |
43,228
-1
| -0% | -$18 | ﹤0.01% | 92 |
|
|
2024
Q3 | $479K | Hold |
43,229
| – | – | ﹤0.01% | 103 |
|
|
2024
Q2 | $402K | Hold |
43,229
| – | – | ﹤0.01% | 107 |
|
|
2024
Q1 | $1.42M | Hold |
43,229
| – | – | 0.01% | 113 |
|
|
2023
Q4 | $1.16M | Sell |
43,229
-3,065
| -7% | -$82K | 0.01% | 102 |
|
|
2023
Q3 | $2.8M | Hold |
46,294
| – | – | 0.01% | 103 |
|
|
2023
Q2 | $4.72M | Sell |
46,294
-9,133
| -16% | -$930K | 0.02% | 104 |
|
|
2023
Q1 | $9.8M | Sell |
55,427
-2,190
| -4% | -$387K | 0.05% | 101 |
|
|
2022
Q4 | $22.3M | Sell |
57,617
-11,827
| -17% | -$4.57M | 0.13% | 79 |
|
|
2022
Q3 | $23.4M | Hold |
69,444
| – | – | 0.13% | 94 |
|
|
2022
Q2 | $22.8M | Hold |
69,444
| – | – | 0.12% | 94 |
|
|
2022
Q1 | $30.4M | Buy |
69,444
+13,888
| +25% | +$6.07M | 0.15% | 81 |
|
|
2021
Q4 | $24.4M | Hold |
55,556
| – | – | 0.12% | 83 |
|
|
2021
Q3 | $30.9M | Hold |
55,556
| – | – | 0.14% | 83 |
|
|
2021
Q2 | $28.5M | Sell |
55,556
-12,916
| -19% | -$6.64M | 0.12% | 87 |
|
|
2021
Q1 | $53.5M | Hold |
68,472
| – | – | 0.27% | 69 |
|
|
2020
Q4 | $37.3M | Buy |
68,472
+5,972
| +10% | +$3.25M | 0.22% | 72 |
|
|
2020
Q3 | $28.6M | Sell |
62,500
-1,389
| -2% | -$636K | 0.2% | 77 |
|
|
2020
Q2 | $39.3M | Hold |
63,889
| – | – | 0.31% | 64 |
|
|
2020
Q1 | $30.4M | Hold |
63,889
| – | – | 0.26% | 55 |
|
|
2019
Q4 | $37.1M | Buy |
63,889
+4,167
| +7% | +$2.42M | 0.25% | 61 |
|
|
2019
Q3 | $39.3M | Buy |
59,722
+33,296
| +126% | +$21.9M | 0.3% | 50 |
|
|
2019
Q2 | $20.5M | Buy |
+26,426
| New | +$20.5M | 0.13% | 76 |
|